Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -238.85%.
GROSS MARGIN
N/A
GROSS MARGIN AVG TTM
-98.06%
GROSS MARGIN AVG 3Y
94.52%
GROSS MARGIN AVG 5Y
60.41%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CytoMed Therapeutics Limited
Market Cap
$10.41M
Gross Margin
N/A
TTM Avg
-98.06%
3Y Avg
94.52%
5Y Avg
60.41%
Market Cap
$10.18M
Gross Margin
0.00%
TTM Avg
44.31%
3Y Avg
60.00%
5Y Avg
55.54%
Market Cap
$10.74M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.10M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.97M
Gross Margin
-16431.82%
TTM Avg
-8215.91%
3Y Avg
-4057.95%
5Y Avg
-2671.97%
Market Cap
$9.92M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $10.41M | N/A | -98.06% | 94.52% | 60.41% |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | N/A | 0.00% | 0.00% | 0.00% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 0.00% | 44.31% | 60.00% | 55.54% |
| Lifeward Ltd. (LFWD)vs › | $10.65M | 35.95% | 35.13% | 34.24% | 39.24% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | 0.00% | 0.00% | 0.00% | 0.00% |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | 0.00% | 0.00% | 10.16% | 1.65% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | -16431.82% | -8215.91% | -4057.95% | -2671.97% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioVie Inc. (BIVI)vs › | $11.01M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
N/A
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -238.85% |
| 2025-12-31 | -330.85% |
| 2025-09-30 | 84.40% |
| 2025-06-30 | 93.07% |
| 2025-03-31 | 93.07% |
| 2024-12-31 | 174.87% |
| 2024-09-30 | 89.67% |
| 2024-06-30 | 99.02% |
| 2024-03-31 | 99.01% |
| 2023-12-31 | 98.94% |
| 2023-09-30 | 98.94% |
| 2023-06-30 | -44.62% |
| 2023-03-31 | 97.85% |
| 2022-12-31 | 98.28% |
| 2022-09-30 | 98.27% |
| 2022-06-30 | -156.47% |
| 2022-03-31 | 94.99% |
| 2021-12-31 | -127.84% |
| 2021-09-30 | 95.88% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 84.43% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
